OBOlga V. Borschcheva

Olga V. Borschcheva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olga V. Borschcheva has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Signaling pathway MEK1/2–ERK1/2 is involved in the cardioprotective effect of probiotic strains in the systemic inflammatory response in rats

    by Yu. Yu. Borshchev, S. M. Minasyan, I. Yu. Burovenko, A. D. Gordeev, V. Yu. Borshchev, O. V. Borshcheva, M. M. Galagudza

    Aim. To experimentally test the hypothesis of the participation of MEK1/2 and ERK1/2 kinases in the mechanism of the probiotic cardioprotection in the implementation of the signaling stage of the cardioprotective response to the administration of probiotic strains in the systemic inflammatory response in rats. Materials and methods. The experiments were performed on male Wistar rats using a model of systemic inflammatory response syndrome, which includes obesity and chemically induced colitis. To provide probiotic cardioprotective effects, the animals were administered probiotic strains LA-5 and BB-12 orally. An inhibitor of MEK1/2 kinase and its associated ERK1/2 kinase PD98059 at a dose of 0.3 mg/kg were administered intravenously 20 minutes before the start of Langendorff perfusion of an isolated heart., The size of the necrosis zone (SNZ) was histochemically determined after 30 minutes of global ischemia and 90 minutes of reperfusion were simulated. Markers of the systemic inflammatory response (SIR) were detected in the blood. Results. In the group of rats on the model of SIR in comparison with the control, a significant increase in the number of leukocytes and an increase in the level of proinflammatory cytokines in the blood, as well as a significant increase in SNZ (by 39% in relation to CTR, p < 0.05). In the group with probiotic correction, a significantly lower SNZ was noted in relation to SIR, whereas in rats with the introduction of probiotics and the substance PD98059, SNZ was significantly higher, i.e. the cancellation of the cardioprotective effect of probiotic therapy occurred. Conclusion. Based on the conclusion that the cardioprotective effect has been abolished by PD98059 administration, it can be assumed that the probiotic effect is provided by the MEK1/2 and ERK1/2 kinase pathways.

  • Open Access

    Cardioprotective Effect of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Is Mediated by Sarcolemmal but Not Mitochondrial ATP-Sensitive Potassium Channels in Rats with Systemic Inflammation

    by Yury Yu. Borshchev, Inessa Yu. Burovenko, Alena B. Karaseva, Sarkis M. Minasian, Alexey D. Gordeev, Victor Yu. Borshchev, Dmitry Yu. Butko, Olga V. Borshcheva, Alexander N. Suvorov, Michael M. Galagudza

    In this study, we investigated the role of mitochondrial and sarcolemmal ATP-sensitive potassium channels (mKATP and sKATP, respectively) in the mechanisms of cardioprotection afforded by a combination of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12) in rats with systemic inflammatory response (SIR), which included diet-induced obesity and chemically induced colitis. Selective mKATP and sKATP blockers were used for assessment of their involvement in the mechanisms of probiotic preconditioning, while myocardial tolerance to ischemia–reperfusion injury was determined in the isolated perfused heart subjected to global ischemia–reperfusion. Intragastric administration of lyophilized LA-5 and BB-12 at a dose of 1.2 × 108 CFU/mL for 7 days resulted in myocardial infarct size reduction. This cardioprotective effect was associated with specific changes in cytokine concentrations, namely, reduced levels of interleukin-1β, tumor necrosis factor-α, and interferon-γ. Moreover, probiotic therapy reversed SIR-induced reduction in the abundance of Lactobacillus spp. in the gut and SIR-induced elevation of acetic and propionic short-chain fatty acids in the blood. Preischemic pharmacological inhibition of sKATP channels but not mKATP channels abolished cardioprotective effect of probiotics. Therefore, it was suggested that sKATP channels are implicated in myocardial protection elicited by probiotics.


  • Open Access

    Effect of probiotic strains, L-arginine and carvedilol on myocardial infarction size in systemic inflammation in rats

    by Yu. Yu. Borshchev, S. M. Minasyan, I. Yu. Burovenko, E. S. Protsak, V. Yu. Borshchev, O. V. Borshcheva, M. M. Galagudza, Ю. Ю. Борщев

    Aim. To determine the cardioprotective effect of a mixture of probiotic strains of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. Lactis (BB-12) in rats with systemic inflammatory response syndrome (SIRS) in comparison with the use of α- and β-adrenoblocker carvedilol and L-arginine, the precursor of nitric oxide (NO).Materials and methods. Experiments were conducted on male Wistar rats in a model of SIRS including obesity and chemically induced colitis. Probiotic strains (PRK), L-arginine (ARG), and the α- and β-adrenoblocker carvedilol (ADB) were intragastrically administered to animals of the corresponding groups. Myocardial ischemia-reperfusion injury was reproduced in an isolated heart perfusion model. The size of the necrosis zone (SNZ) was determined using histochemistry. The concentration of cytokines in blood plasma was measured using an immunoenzyme technique.Results. Myocardial SNZ in the group with SIRS modeling was significantly higher than in the control group (45 (38; 48)% and 30 (26; 31)%, p < 0.05). In the PRK and ARG groups, the SNZ was 32 (28; 35)% and 35 (26; 36)%, respectively, which was significantly lower compared to the SIRS group (p < 0.05). In the ADB group, the SNZ was 40 (31; 48)%, similar to the value in the SIRS group (p > 0.05). Hemodynamic parameters in isolated heart did not differ between the groups. The concentration of proinflammatory cytokines and transforming growth factor-β in plasma was significantly higher in the SIRS group than in the control. At the same time, in the PRK and ARG groups there was a significant decrease in the levels of some cytokines, confirming the presence of anti-inflammatory effect.Conclusion. Administration of PRK in rats with the model of SIRS caused a decrease in SNZ. At the same time, blockade of α- and β-adrenoreceptors was not accompanied by a decrease in SNZ in this model. The amino acid L-arginine had similar to the PRK group cardioprotective and anti-inflammatory effect, which may indicate the similarity of the tested effects.

  • Changes in the activity of amylase, alkaline phosphatase and lipase in placenta and umbilical cord blood in women in labor with gestational diabetes mellitus

    by Elena V. Kolodkina, Sergey A. Lytaev, Michael M. Galagudza, Alexander B. Loginov, Tatyana M. Pervunina, Stanislav I. Sitkin, Yuri Yu. Borschchev, Olga V. Borschcheva, Борщев Юрий Юрьевич

    BACKGROUND: The prevalence of gestational diabetes mellitus in the world is increasing every year. However, there is a small number of studies on changes in enzymes of various classes in blood serum in gestational diabetes mellitus, and there are conflicting results regarding the concentration of individual enzymes. AIM: To study the activity of amylase, alkaline phosphatase and lipase in placenta and umbilical cord blood in women in labor with gestational diabetes mellitus in comparison with women without this pathology. METHODS: Cord blood and placenta sections were obtained from women with (n = 20) and without (n = 62) gestational diabetes mellitus during labor in the presence of informed consent. Alkaline phosphatase and lipase activity was estimated by kinetic colorimetric method, amylase activity by amyloclastic method according to Caraway. RESULTS: It has been shown that in pregnant women with gestational diabetes mellitus who are on diet therapy, significant differences in the activity of amylase and alkaline phosphatase are present in the homogenate of the placenta and umbilical cord blood compared with pregnant women without gestational diabetes mellitus. In pregnant women without gestational diabetes mellitus and women on insulin therapy, no significant differences were found in the studied fluids according to these enzymes. There were no significant differences in the lipolytic activity of umbilical cord blood and placental homogenate between the groups of women studied. CONCLUSION: The study showed that gestational diabetes mellitus in women leads to significant changes in the activity of enzymes in the homogenate of the placenta and umbilical cord blood.


  • The effect of probiotic bacteria and pharmacological anti-inflammatory effects on the size of myocardial infarction in rats with systemic inflammation

    by Yuri Yu. Borshchev, Sarkis M. Minasyan, Inessa Yu. Burovenko, Egor S. Protsak, Victor Yu. Borshchev, Olga V. Borshcheva, Michael M. Galagudza, Борщев Юрий Юрьевич, Борщев Виктор Юрьевич

    BACKGROUND: In recent years, it has been shown that certain probiotics have a cardioprotective effect in conditions of comorbidity and systemic inflammation. The mechanisms of probiotic-mediated cardioprotection have not been studied in practice. There is an assumption that the heart attack-limiting effect of probiotics is mediated by their anti-inflammatory effect. AIM: To study the severity of the cardioprotective effect of a mixture of probiotic strains of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12) in rats with systemic inflammatory response syndrome in comparison with the use of IL-1 receptor blockers, AT1 angiotensin II receptors, M-cholinergic receptors, as well as an inhibitor of tumor necrosis factor alfa binding to its receptors. METHODS: The experiments were performed on male Wistar stock rats on a model of systemic inflammatory response syndrome. The rats of the corresponding groups, after chemical induction of a systemic inflammatory response, were intragastrically injected with probiotic strains, losartan and hyoscine butyl bromide; subcutaneously — etanercept and anakinra for 8 days. The assessment of myocardial resistance to ischemic-reperfusion injury was carried out on the model of global ischemia-reperfusion of an isolated heart at an upgraded Langendorff facility, by planimetric estimation of the size of the necrosis zone. The concentration of cytokines in blood plasma was assessed by enzyme immunoassay. RESULTS: The size of the myocardial necrosis zone in the systemic inflammatory response group, rats with systemic inflammatory response syndrome, was significantly higher than in the control group — 45% (38; 48)% and 30% (26; 31)% (p 0.05). In the groups of probiotic strains, anakinra and losartan, the size of the necrosis zone was 32% (28; 35)%, 26% (24; 35)% and 30% (25; 36)%, which is less than in the systemic inflammatory response group (p 0.05). In the etanercept and hyoscine butyl bromide groups, the size of the necrosis zone was 35% (26; 36)% and 42% (32; 46)%, not significantly different from the SIR group (p 0.05). Hemodynamic parameters of the isolated heart did not differ between the groups. In the systemic inflammatory response group, the concentration of proinflammatory cytokines and transforming growth factor beta in blood plasma was significantly higher than in the control group. At the same time, in the groups of probiotic strains, anakinra, losartan and hyoscine butyl bromide, a significant decrease in the levels of certain cytokines was noted, confirming the presence of an anti-inflammatory effect. CONCLUSION: The introduction of probiotics to rats with systemic inflammatory response syndrome caused a decrease in the size of the necrosis zone. At the same time, the blockade of tumor necrosis factor alfa binding to receptors and the blockade of M-cholinergic receptors were not accompanied by a decrease in size of the necrosis zone in this model. Pharmacological blockade of the IL-1 and AT1 angiotensin II receptors had a cardioprotective and anti-inflammatory effect similar to the probiotic strains group, which indicates the unidirectional effect of the tested effects.

  • Open Access

    Effect of intestinal microbiota on myocardial resistance to ischemia-reperfusion injury

    by Yu. Yu. Borshchev, D. L. Sonin, S. M. Minasyan, O. V. Borshcheva, I. Yu. Burovenko, M. M. Galagudza, Ю. Ю. Борщев

    The last 10–15 years have been marked by a rapid increase in the volume of knowledge about the role of the intestinal microbiota in the regulation of various physiological processes. In particular, the interrelations between disturbances in the composition of the intestinal microflora and an increase in the risk of developing cardiovascular diseases were noted. There are also emerging works that demonstrate the possibility of reducing the severity of myocardial ischemia-reperfusion injury as a result of various effects on the composition of intestinal microbiota. This review analyzes the recent literature on the influence of intestinal microbiota on myocardial resistance to ischemia-reperfusion injury. It has been shown that modulation of the intestinal microbiome by changing the nature of nutrition, probiotics, antibiotics, and intestinal microflora transplantation leads to a reduction in the size of myocardial infarction. Normalization of increased permeability of intestinal epithelial barrier with reduction of manifestations of systemic inflammation, changes in the level of secretion of some hormones, increased production of short-chain fatty acids and modulation of bile acid metabolism under the action of intestinal bacterial enzymes are considered as possible mechanisms of cardioprotection mediated by changes in the functional state of microbiota. The concept of increasing myocardial resistance to ischemia-reperfusion injury by modulating the composition of the intestinal microbiota is a completely new scientific direction that requires detailed study in experiment with the possibility of rapid implementation of the results obtained in clinical practice.


  • Open Access

    Probiotic Therapy with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis

    by Yury Y. Borshchev, Inessa Y. Burovenko, Alena B. Karaseva, Sarkis M. Minasian, Egor S. Protsak, Victor Y. Borshchev, Natalia Y. Semenova, Olga V. Borshcheva, Alexander N. Suvorov, Michael M. Galagudza

    In this study, we investigated the effect of three different probiotics, namely, a combination of Lactobacillus acidophilus (LA–5) and Bifidobacterium animalis subsp. lactis (BB–12), Saccharomyces boulardii, and Enterococcus faecium L3 on myocardial infarct size in rats with diet-induced obesity (DIO) and chemically-induced colitis (CIC). Potential associations between the effects of probiotics on myocardial ischemia-reperfusion injury and gut microbiome patterns as well as the serum levels of pro- and anti-inflammatory cytokines, lipopolysaccharide, and short chain fatty acids were also studied. Intragastric administration of lyophilized Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis at a dose of 1.2 × 108 CFU/mL for 15 days resulted in myocardial infarct size reduction in rats with DIO, CIC, and antibiotic-induced dysbiosis. This cardioprotective effect was associated with specific changes in cytokine concentrations, namely reduced levels of IL–1β, TNF–α, IL–2, and IL–8. At the same time, the use of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis was accompanied by a significant reduction in lipopolysaccharide level, suggesting normalization of intestinal epithelial barrier permeability. However, the cardioprotective effect of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis is not secondary to improved healing of the intestinal mucosa in CIC, as evidenced by the lack of difference in histopathological scores.